Braf targets in melanoma : biological mechanisms, resistance, and drug discovery / edited by Ryan J. Sullivan.
Tipo de material:
TextoSeries Cancer Drug Discovery and Development ; 82Editor: New York, NY : Springer New York : Springer, 2015Descripción: viii, 204 páginas : 26 ilustraciones, 21 ilustraciones en colorTipo de contenido: - texto
- computadora
- recurso en línea
- 9781493921430
- RC261-271
Contenidos:
Melanoma: Historical Context -- Melanoma Pathogenesis -- Molecular Diagnostics and Tumor Mutational Analysis -- Clinical Utility of BRAF-targeted therapy in Melanoma -- The Ethics of Randomized Trials in Oncology -- Parallel and Serial Blockade Strategies in BRAF-Mutant Melanoma -- Targeting the cell cycle and p53 in combination with BRAF-directed therapy -- Combination BRAF-directed therapy and immunotherapy -- Moving Forward: Making BRAF-Targeted Therapy Better.
No hay ítems correspondientes a este registro
Springer eBooks
Melanoma: Historical Context -- Melanoma Pathogenesis -- Molecular Diagnostics and Tumor Mutational Analysis -- Clinical Utility of BRAF-targeted therapy in Melanoma -- The Ethics of Randomized Trials in Oncology -- Parallel and Serial Blockade Strategies in BRAF-Mutant Melanoma -- Targeting the cell cycle and p53 in combination with BRAF-directed therapy -- Combination BRAF-directed therapy and immunotherapy -- Moving Forward: Making BRAF-Targeted Therapy Better.
Para consulta fuera de la UANL se requiere clave de acceso remoto.